0
Exagen Inc. Banner Image

Exagen Inc. has reached its limit for free report views

Work for Exagen Inc.? Upgrade Your Profile and unlock all your annual reports.

Exagen Inc.

  • Ticker XGN
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Exagen Inc. Logo Image
  • 51-200 Employees
  • Based in Vista, California
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand. Several of these products are based on their proprietary Cell-BoundMore Complement Activation Products (CB-CAPs), technology. CB-CAPs assess the activation of the complement system, a biological pathway implicated in systemic lupus erythematosus (SLE). Exagen’s goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis, or RA. Exagen’s model of integrating testing products and therapeutics positions Exagen to offer targeted solutions to rheumatologists and, ultimately, better serve patients.
Exagen Inc.

Most Recent Annual Report

Exagen Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Exagen Inc. has reached its limit for free report views.